rigel pharmaceuticals inc
(RIGL:Consolidated Issue Listed on NASDAQ Global Select )
Ryan D. Maynard
Chief Financial Officer and Executive Vice President, Rigel Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Ryan D. Maynard has been the Chief Financial Officer of Rigel Pharmaceuticals Inc. since January 2007. Mr. Maynard has been an Executive Vice President of Rigel Pharmaceuticals, Inc. since June 2010. He served as Acting Chief Financial Officer and Vice President of Finance at Rigel Pharmaceuticals, Inc. since June 2006. He served as Vice President of Finance and Acting Chief Financial Officer of Rigel Pharmaceuticals, Inc. since June 1, 2006. He joined Rigel in September ...
1180 Veterans BoulevardPhone: 650-624-1100
South San Francisco, California 94080
Board Members Memberships*
Director and Chairman of Audit Committee
Santa Clara University
|Paolo Pucci||Chief Executive Officer and Director|
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Myung-Joong Cho Ph.D.||Founder, Chief Executive Officer and President|
|--||Compensation as of Fiscal Year 2014.|